counterfeit semaglutide legal status fda Attorneys general urge to crack down on obesity drugs FDA warns of fake Ozempic

Understanding how reconstitution math changes between the two prevents costly confusion

Check back for more stories about the lesser-known downsides of these wildly popular medications

The potential of the emerging Glucagon-like Peptide-1 (GLP-1) Agonists in changing the current clinical practice guidelines is crucial to analyze, especially when it comes to real-world scenarios

Safety and efficacy analyses across age and body mass index subgroups in East Asian participants with type 2 diabetes in the phase 3 tirzepatide studies (SURPASS programme)

Current international, Australian and State guidelines Professor Erwin Loh 6y The Four Stages of Coronavirus Lockdown Explained Professor Erwin Loh 6y A short message to all our Healthcare Workers during this pandemic crisis from a grateful colleague Professor Erwin Loh 6y

Frequently Asked Questions Is GLP-1 agonists the same as Ozempic